Barnes Michael Gene

SEC source: 0000950170-25-114590 · ownership.xml · derivative · entry 9

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 112,015 shares

Expires 2027-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · security: On February 22, 2017, the Reporting Person was granted non-qualified stock options to purchase 112,015 shares of common stock of the Registrant at $6.65 per share, subject to the terms of a Stock Option Agreement.

F11 · derivative.exercise_date: The option shares are fully vested and exercisable as of February 22, 2022.

SEC source: 0000950170-25-114590 · ownership.xml · derivative · entry 8

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,649 shares

Expires 2026-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: On March 10, 2016, the Reporting Person was granted non-qualified stock options to purchase 4,649 shares of common stock of the Registrant at $5.87 per share, subject to the terms of a Stock Option Agreement.

F9 · derivative.exercise_date: The option shares are fully vested and exercisable as of March 10, 2021.

SEC source: 0000950170-25-114590 · ownership.xml · derivative · entry 7

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,494 shares

Expires 2026-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: On January 4, 2016, the Reporting Person was granted non-qualified stock options to purchase 46,494 shares of common stock of the Registrant at $5.67 per share, subject to the terms of a Stock Option Agreement.

F7 · derivative.exercise_date: The option shares are fully vested and exercisable as of January 4, 2021.

SEC source: 0000950170-25-114590 · ownership.xml · nonDerivative · entry 6

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,085,428

F5 · kind: Reflects 29,224 shares withheld by the Issuer at the market price of $25.49 per share less an exercise price of $6.65 per share to fund the cashless exercise of 112,015 options.

F3 · price: Represents the closing stock price as of the transaction date.

SEC source: 0000950170-25-114590 · ownership.xml · nonDerivative · entry 5

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,114,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported above in Table I reflect the cashless exercise of stock options. The cashless exercise for the options is reported in two lines. The lines coded M in column 3 of Table I report in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The lines coded F in column 3 of Table I relates to the same cashless exercise on the preceding line and reports in Column 4 the number of shares deducted from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed.

SEC source: 0000950170-25-114590 · ownership.xml · nonDerivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,002,637

F4 · kind: Reflects 1,071 shares withheld by the Issuer at the market price of $25.49 per share less an exercise price of $5.87 per share to fund the cashless exercise of 4,649 options.

F3 · price: Represents the closing stock price as of the transaction date.

SEC source: 0000950170-25-114590 · ownership.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,003,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported above in Table I reflect the cashless exercise of stock options. The cashless exercise for the options is reported in two lines. The lines coded M in column 3 of Table I report in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The lines coded F in column 3 of Table I relates to the same cashless exercise on the preceding line and reports in Column 4 the number of shares deducted from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed.

SEC source: 0000950170-25-114590 · ownership.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,999,059

F2 · kind: Reflects 10,343 shares withheld by the Issuer at the market price of $25.49 per share less an exercise price of $5.67 per share to fund the cashless exercise of 46,494 options.

F3 · price: Represents the closing stock price as of the transaction date.

SEC source: 0000950170-25-114590 · ownership.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,009,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported above in Table I reflect the cashless exercise of stock options. The cashless exercise for the options is reported in two lines. The lines coded M in column 3 of Table I report in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The lines coded F in column 3 of Table I relates to the same cashless exercise on the preceding line and reports in Column 4 the number of shares deducted from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed.

SEC source: 0001393726-25-000019 · wk-form4_1740604658.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,962,908

SEC source: 0001393726-24-000099 · wk-form4_1730491366.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These PRSUs were granted to the Reporting Person on August 4, 2021. Each PRSU will vest upon Tiptree achieving each of three Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $30 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Each PRSU represents a contingent right to receive one share of Tiptree common stock. Any unvested PRSUs shall expire on August 4, 2031.

F2 · derivative.exercise_date: These PRSUs were granted to the Reporting Person on August 4, 2021. Each PRSU will vest upon Tiptree achieving each of three Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $30 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Each PRSU represents a contingent right to receive one share of Tiptree common stock. Any unvested PRSUs shall expire on August 4, 2031.

F2 · derivative.expiration_date: These PRSUs were granted to the Reporting Person on August 4, 2021. Each PRSU will vest upon Tiptree achieving each of three Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $30 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Each PRSU represents a contingent right to receive one share of Tiptree common stock. Any unvested PRSUs shall expire on August 4, 2031.

SEC source: 0001393726-24-000099 · wk-form4_1730491366.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,902,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The acquisition of the common stock resulted from the vesting of an equal number of performance restricted stock units ("PRSUs") upon achieving the $20 Tiptree Inc. ("Tiptree") share price target milestone (adjusted for dividends paid).

SEC source: 0001393726-24-000002 · wk-form4_1704229431.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 550,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit (PRSU) represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving a share price target milestone based on the average of the thirty (30) trading day closing stock price of $70 (adjusted for dividends paid) prior to the 10th anniversary of the grant date, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on January 1, 2034.

F1 · derivative.exercise_date: Each performance restricted stock unit (PRSU) represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving a share price target milestone based on the average of the thirty (30) trading day closing stock price of $70 (adjusted for dividends paid) prior to the 10th anniversary of the grant date, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on January 1, 2034.

F1 · derivative.expiration_date: Each performance restricted stock unit (PRSU) represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving a share price target milestone based on the average of the thirty (30) trading day closing stock price of $70 (adjusted for dividends paid) prior to the 10th anniversary of the grant date, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on January 1, 2034.

SEC source: 0001393726-22-000080 · wf-form4_166205835088757.xml · derivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,015

Underlying: Common Stock · 112,015 shares

Expires not disclosed

F6 · security: On February 22, 2017, in consideration of Michael Barnes's service to the Registrant, Corvid Peak Holdings, L.P. (fka Tricadia Holdings L.P. "Corvid Peak") was granted options to purchase 219,472 shares of common stock of the Registrant subject to the terms of a Stock Option Agreement among the Registrant, Michael Barnes and Corvid Peak, which was reported as Indirectly held on the date of grant. On September 1, 2022, Corvid Peak distributed all 219,472 Stock Options to its partners, pro rata. The Reporting Person received as his pro rata portion 112,015 Stock Options which are now held Direct.

F2 · derivative.exercise_date: Exercise of these stock options is from the grant date.

F7 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 22, 2027 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant.

SEC source: 0001393726-22-000080 · wf-form4_166205835088757.xml · derivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,649

Underlying: Common Stock · 4,649 shares

Expires not disclosed

F4 · security: On March 10, 2016, in consideration of Michael Barnes's services to the Registrant, Corvid Peak Holdings, L.P. (fka Tricadia Holdings, L.P. "Corvid Peak") was granted stock options to purchase 9,136 shares of common stock of the Registrant subject to the terms of a Stock Option Agreement among the Registrant, Michael Barnes and Corvid Peak. On September 1, 2022, Corvid Peak distributed all 9,136 Stock Options to its partners, pro rata. The Reporting Person received as his pro rata portion 4,649 Stock Options which are now held Direct.

F2 · derivative.exercise_date: Exercise of these stock options is from the grant date.

F5 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) March 10, 2026 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant.

SEC source: 0001393726-22-000080 · wf-form4_166205835088757.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,494

Underlying: Common Stock · 46,494 shares

Expires not disclosed

F1 · security: On January 4, 2016, in consideration of Michael Barnes's services to the Registrant, Corvid Peak Holdings, L.P. (fka Tricadia Holdings L.P. "Corvid "Peak") was granted stock options to purchase 91,359 shares of common stock of the Registrant subject to the terms of a Stock Option Agreement among the Registrant, Michael Barnes and Corvid Peak. On September 1, 2022, Corvid Peak distributed all 91,359 Stock Options to its partners, pro rata. The Reporting Person received as his pro rata portion 46,494 Stock Options which are now held Direct.

F2 · derivative.exercise_date: Exercise of these stock options is from the grant date.

F3 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) January 4, 2026 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant.

SEC source: 0001393726-22-000048 · wf-form4_165420096209672.xml · derivative · entry 4

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 979,146 shares

Expires 2022-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 1, 2022, the Reporting Person exercised the 2022 Warrants at the adjusted exercise price of $6.927. Tiptree received cash proceeds of $6,782,544.34 from the exercise of the 2022 Warrants.

SEC source: 0001393726-22-000048 · wf-form4_165420096209672.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,702,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 1, 2022, the Reporting Person exercised the 2022 Warrants at the adjusted exercise price of $6.927. Tiptree received cash proceeds of $6,782,544.34 from the exercise of the 2022 Warrants.

SEC source: 0001393726-21-000119 · wf-form4_163761843624713.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

F2 · derivative.exercise_date: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

F2 · derivative.expiration_date: The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031.

SEC source: 0001393726-21-000119 · wf-form4_163761843624713.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,722,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The acquisition of the common stock resulted from the vesting of an equal number of performance restricted stock units ("PRSUs") granted on August 4, 2021. Each PRSU represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock.

SEC source: 0001393726-21-000093 · wf-form4_162818741043273.xml · derivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500,000

Underlying: Common Stock · 1,500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

F1 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Tiptree Inc. ("Tiptree") common stock. The PRSUs will vest upon Tiptree achieving each of five Tiptree share price target milestones, based on the average of the thirty (30) trading day closing stock price, ranging from $15 to $60 (adjusted for dividends paid) prior to the tenth anniversary of the date of grant, subject to the Reporting Person's continued employment with Tiptree. Any unvested PRSUs shall expire on August 4, 2031. See the Remarks below for the share price target milestones.

SEC source: 0001393726-20-000269 · wf-form4_160406585445420.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,622,949

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.98 to $5.05, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000267 · wf-form4_160398073241536.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,621,649

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.06 to $5.16, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000267 · wf-form4_160398073241536.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619,183

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.20 to $5.24, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000265 · wf-form4_160380745212546.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,616,717

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.20 to $5.24, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000265 · wf-form4_160380745212546.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,614,251

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.20 to $5.30, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000263 · wf-form4_160346175955012.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,611,774

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.28 to $5.32, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000263 · wf-form4_160346175955012.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,609,297

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.30 to $5.37, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000259 · wf-form4_160328966239623.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,606,820

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.25 to $5.32, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000259 · wf-form4_160328966239623.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,604,343

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.24 to $5.30, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000256 · wf-form4_160312107175246.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,601,866

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.15 to $5.30 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000256 · wf-form4_160312107175246.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,598,814

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.11 to $5.20, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000254 · wf-form4_160277201937025.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,595,762

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.14 to $5.20 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000254 · wf-form4_160277201937025.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,592,710

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.17 to $5.21, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000244 · wf-form4_160260009356217.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,589,658

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F4 · price: This purchase was executed in multiple purchases at prices ranging from $5.16 to $5.25, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000244 · wf-form4_160260009356217.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,586,606

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.15 to $5.28 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000244 · wf-form4_160260009356217.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,583,754

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.10 to $5.24, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000242 · wf-form4_160217075238434.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,580,902

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.98 to $5.12 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000242 · wf-form4_160217075238434.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,578,050

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.95 to $5.10, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000240 · wf-form4_160199205757207.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,575,198

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.90 to $5.00 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000240 · wf-form4_160199205757207.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,572,346

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.82 to $4.94, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000238 · wf-form4_160165470986166.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,569,543

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.84 to $4.98 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000238 · wf-form4_160165470986166.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,566,740

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.94 to $5.00, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000236 · wf-form4_160147449216945.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,563,937

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.87 to $4.95 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000236 · wf-form4_160147449216945.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,561,134

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.87 to $5.07, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000234 · wf-form4_160130317144682.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,558,331

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.67 to $4.88 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000234 · wf-form4_160130317144682.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,555,848

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.62 to $4.69, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000232 · wf-form4_160095565804862.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,553,365

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.59 to $4.75 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000232 · wf-form4_160095565804862.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,550,882

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.55 to $4.75, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001393726-20-000230 · wf-form4_160078364184340.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,548,399

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.85 to $4.99 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.